Key MRI features (semiotics)
Diagnosis of giant cell tumour of bone (Giant Cell Tumour) is based on identifying specific tissue characteristics. A key feature is the presence of haemosiderin (haemosiderin). This substance accumulates in the solid areas of the neoplasm as a direct consequence of recurrent minor haemorrhages.
Standard sequences are insufficient for reliable visualization of haemosiderin. It is most clearly detected on T2*-weighted gradient-echo images (T2 weighted gradient-echo images*). On these scans, areas of haemosiderin accumulation appear as zones of profound signal loss (profound low SI).
Evaluating contrast enhancement helps differentiate the tumor structure:
- Solid areas are characterized by uniform (homogeneous) contrast enhancement (uniform enhancement).
- Cystic areas enhance differently—predominantly peripherally and along internal septations (peripheral and septal enhancement).
Among associated findings, the radiologist often detects bone marrow edema (marrow oedema). An important prognostic sign is the appearance of fluid-fluid levels. Their presence directly indicates secondary transformation of the tumor into an aneurysmal bone cyst (aneurysmal bone cyst), which is observed in approximately 15% of patients. It should be remembered that malignant giant cell tumors do not possess any unique radiological markers.
Analysis of clinical MRI patterns
Analyzing images of various skeletal segments helps reinforce the understanding of semiotics. When localized in the proximal tibia, the lesion typically exhibits intermediate-to-low signal intensity (intermediate-low SI) on coronal T1-weighted spin-echo images and sagittal T2-weighted fast spin-echo images.
In lesions of the distal femur, the sagittal T2* gradient-echo sequence is most informative. It is precisely here that the structure of the giant cell tumor yields a profoundly low signal intensity, driven by the magnetic susceptibility effect from massive haemosiderin deposits.
Differential diagnosis
Osteoclastoma must be differentiated from a number of other pathologies causing bone tissue destruction. The baseline differential diagnosis list includes lytic osteosarcoma (lytic osteosarcoma).
The patient's age group requires special attention. In elderly individuals, the differential diagnosis broadens significantly and should include:
- Undifferentiated pleomorphic sarcoma (undifferentiated pleomorphic sarcoma).
- Plasmacytoma (plasmacytoma).
- Subarticular lytic metastases (subarticular lytic metastasis). In this category, metastases from primary renal cell carcinoma rank first (primary renal tumour).
Additionally, when discovering isolated focal bone lesions, vascular tumors such as hemangiomas (haemangioma) should not be overlooked. They can be solitary or multiple, representing congenital vascular malformations, and must be included in the general differential diagnosis.
Briefly: answers to topical questions
What is the MR signal intensity of osteoclastoma on standard T1- and T2-weighted images?
On MRI, giant cell tumor of bone presents as a lesion with intermediate-to-low signal intensity on T1- and T2-weighted images. Additionally, T2*-weighted gradient-echo images reveal areas of profoundly low signal intensity due to haemosiderin deposition, which increases the diagnostic specificity of the method. Solid tumor areas show uniform contrast enhancement, while cystic areas show peripheral and septal enhancement.
| Mode | Signal intensity |
|---|---|
| T1WI | intermediate-to-low |
| T2WI | intermediate-to-low |
| T2* gradient-echo | profoundly low (haemosiderin) |
What clinical symptoms accompany the development of giant cell tumor of bone?
Giant cell tumor of bone may be accompanied by a slowly increasing protrusion and deformation of the affected bone, pain, and pathological fractures. For the lytic form, a rapid course, local skin hyperthermia, tenderness upon palpation of the thinned bone, and dilation of mucosal veins are described; the clinical picture may resemble osteolytic sarcoma. When localized in the jaw, tooth displacement and mobility are possible. Absence of regional lymph node reaction and accelerated growth during pregnancy have also been described for jaw osteoclastoma.
Class and exam questions
How to differentiate a benign giant cell tumor from a malignant one on MRI?
Doing this solely based on radiological or MRI features is impossible, as the malignant form lacks specific distinctive imaging characteristics.
In which MRI sequence is it best to look for haemosiderin deposits?
Haemosiderin is optimally visualized on T2*-weighted gradient-echo images, where it appears as areas of profoundly low signal intensity (signal drop-out).
What does the appearance of fluid-fluid levels within the tumor structure indicate?
The presence of fluid-fluid levels indicates secondary transformation of the giant cell tumor into an aneurysmal bone cyst.
What else to study on this topic
- Pathogenesis of haemosiderin formation in microhemorrhages within bone tumors
- Mechanism of fluid-fluid level formation in bone cysts (MRI physics)
- MRI semiotics of lytic osteosarcoma
- Features of renal cell carcinoma metastasis to bone tissue
- Classification and MRI appearance of intraosseous hemangiomas
Master the entire topic in the "Diagnostic Radiology" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Giant cell tumor of bone" and 2,199 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 10 video lessons on the subject
Other topics in the "Musculoskeletal System" section
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.